A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy

Your Location：

Home >

Browse articles >

A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy

Chinese Medical Sciences Journal Vol. 33, Issue 2, Pages: 91-99(2018)

Original Article | Updated：2024-04-10

|

- A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy
- Affiliations：
  
  1 Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China;
  2 Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China;
- Author bio：
- Funds：
- DOI：10.24920/11809
  CLC：
- Received：20 October 2017，
  
  Published Online：20 June 2018，
  
  Published：20 June 2018
- Accepted：
Scan QR Code
Zou Peimei, Li Hang, Cai Jianfang, et al. A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy[J]. Chinese medical sciences journal, 2018, 33(2): 91-99.
DOI：

Zou Peimei, Li Hang, Cai Jianfang, et al. A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy[J]. Chinese medical sciences journal, 2018, 33(2): 91-99. DOI： 10.24920/11809.

摘要

目的

评估特发性膜性肾病（IMN）患者队列中动脉血栓栓塞事件（ATEs）和静脉血栓栓塞事件（VTEs）的发生率及其特点

并探索其相关危险因素。

方法

回顾性研究队列共纳入766名连续中国人IMN患者

以Kaplan-Meier模型统计新发的ATEs和VTEs的累积发病率

以单因素和多因素风险回归分析其可能的危险因素。

结果

在肾活检诊断为IMN后的第0.5、1、2、3、5年中

ATEs的累积发病率分别为4.3%、5.7%、6.3%、7.1%和8.0%

VTEs的累积发病率分别为5.9%、6.8%、6.9%、7.0%和7.2%。在78起ATE事件（71例）中

心血管疾病、血栓性缺血性脑卒中和外周动脉性疾病分别占比50%、45%和5%;在60起VTE事件（53例）中

深静脉血栓、肾静脉血栓和肺栓塞分别占比60%、13%和27%。ATE和VTE事件发生时

分别有42.1%和81.5%的患者处于肾病综合征（NS）状态（χ

2

=18.1

P

<

0.001）。ATEs与大量蛋白尿、年龄、吸烟史、高血压和既往ATE史相关

其中年龄是ATEs的独立危险因素（

P

=0.001）

低白蛋白血症为VTEs主要独立危险因素(

P

=0.03)。

结论

IMN患者ATEs和VTEs发病率高

尤其在病程的前6个月内。ATEs中IS占比高。大量蛋白尿和动脉粥样硬化经典危险因素与ATEs的发生相关

低白蛋白血症为VTEs的独立预测因素。肾病综合征状态时ATEs和VTEs的发生风险增高

特别是VTEs。

Abstract

Objective

The aims of this study were to assess incidences and characteristics of arterial thromboembolic events (ATEs) and venous thromboembolic events (VTEs) in Chinese patients with idiopathic membranous nephropathy (IMN)

and to identify the predisposing risk factors of them.

Methods

A total of 766 consecutive Chinese patients with IMN were enrolled in this retrospective cohort study. The cumulative incidences of newly diagnosed ATEs and VTEs were calculated using Kaplan-Meier methods. Univariable risk prediction model analysis followed by multivariable survival analysis was used to evaluate the potential risk factors of ATE and VTE.

Results

At 0.5

1

2

3

and 5 years after biopsy diagnosis of IMN

the cumulative incidence of newly diagnosed ATEs were 4.3%

5.7%

6.3%

7.1%

and 8.0%

and of newly diagnosed VTEs were 5.9%

6.8%

6.9%

7.0%

and 7.2%

respectively. In 78 ATEs events (71 patients)

cardiovascular diseases

thrombotic ischemic stroke (IS) and peripheral artery disease accounted for 50%

45% and 5% respectively; in 60 VTEs events(53 patients)

the deep vein thrombosis

renal vein thrombosis and pulmonary embolism accounted for 60%

13% and 27% respectively. At the time of event

42.1% patients with ATEs and 81.5% patients with VTEs were at nephrotic syndrome(NS) status (

χ

2

=18.1

P

<

0.001). Severe proteinuria

aging

smoking

hypertension and prior ATE history were associated with ATEs. Aging was demonstrated as the independent risk factor for ATEs (

P

=0.001)

and hypoalbuminemia was the dominant independent risk factor for VTEs (

P

=0.03).

Conclusions

Patients with IMN have increased incidences of ATEs and VTEs

and most of events occurred within the first 6 months of the disease. IS was very common in ATEs in our cohort. Severe proteinuria and classic risk factors for atherosclerosis were associated with onset of ATEs. Hypoalbuminemia independently predicted VTEs. Risks of both ATEs and VTEs were particularly high in the status of NS

particularly VTEs.

关键词

Keywords

references

Cattran D . Management of membranous nephropathy: when and what for treatment . J Am Soc Nephrol 2005 ; 16 ( 5 ): 1188 - 94 . doi: 10.1681/ASN.2005010028 10.1681/ASN.2005010028 . DOI: 10.1681/ASN.2005010028 http://doi.org/10.1681/ASN.2005010028 http://www.jasn.org/cgi/doi/10.1681/ASN.2005010028 http://www.jasn.org/cgi/doi/10.1681/ASN.2005010028

Pan X , Xu J , Ren H , et al . Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China . Contrib Nephrol 2013 ; 181 : 22 - 30 . doi: 10.1159/000348638 10.1159/000348638 . DOI: 10.1159/000348638 http://doi.org/10.1159/000348638 https://www.karger.com/Article/FullText/348638 https://www.karger.com/Article/FullText/348638

Barbour SJ , Greenwald A , Djurdjev O , et al . Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis . Kidney Int 2012 ; 81 ( 2 ): 190 - 5 . doi: 10.1038/ki.2011.312 10.1038/ki.2011.312 . DOI: 10.1038/ki.2011.312 http://doi.org/10.1038/ki.2011.312 http://linkinghub.elsevier.com/retrieve/pii/S0085253815552708 http://linkinghub.elsevier.com/retrieve/pii/S0085253815552708

Glassock RJ . Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum . J Am Soc Nephrol 2007 ; 18 ( 8 ): 2221 - 5 . doi: 10.1681/ASN.2006111300 10.1681/ASN.2006111300 . DOI: 10.1681/ASN.2006111300 http://doi.org/10.1681/ASN.2006111300 http://www.jasn.org/cgi/doi/10.1681/ASN.2006111300 http://www.jasn.org/cgi/doi/10.1681/ASN.2006111300

Kayali F , Najjar R , Aswad F , et al . Venous thromboembolism in patients hospitalized with nephrotic syndrome . Am J Med 2008 ; 121 ( 3 ): 226 - 30 . doi: 10.1016/j.amjmed.2007.08.042 10.1016/j.amjmed.2007.08.042 . DOI: 10.1016/j.amjmed.2007.08.042 http://doi.org/10.1016/j.amjmed.2007.08.042 http://linkinghub.elsevier.com/retrieve/pii/S0002934307009813 http://linkinghub.elsevier.com/retrieve/pii/S0002934307009813

Gilboa N . Letter: Incidence of coronary heart disease associated with nephrotic syndrome . Med J Aust 1976 ; 1 ( 7 ): 207 - 8 . http://europepmc.org/abstract/MED/1272153 http://europepmc.org/abstract/MED/1272153

Ordoñez JD , Hiatt RA , Killebrew EJ , et al . The increased risk of coronary heart disease associated with nephrotic syndrome . Kidney Int 1993 ; 44 ( 3 ): 638 - 42 . doi: 10.1038/ki.1993.292 10.1038/ki.1993.292 . DOI: 10.1038/ki.1993.292 http://doi.org/10.1038/ki.1993.292 http://linkinghub.elsevier.com/retrieve/pii/S0085253815581738 http://linkinghub.elsevier.com/retrieve/pii/S0085253815581738

Wass VJ , Jarrett RJ , Chilvers C , et al . Does the nephrotic syndrome increase the risk of cardiovascular disease? Lancet 1979 ; 2 ( 8144 ): 664 - 7 . doi: 10.1016/s0140-6736(79)92067-1 10.1016/s0140-6736(79)92067-1 . DOI: 10.1016/S0140-6736(79)92067-1 http://doi.org/10.1016/S0140-6736(79)92067-1 http://www.ncbi.nlm.nih.gov/pubmed/90759 http://www.ncbi.nlm.nih.gov/pubmed/90759

Mahmoodi BK , ten Kate MK , Waanders F , et al . High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study . Circulation 2008 ; 117 ( 2 ): 224 - 30 . doi: 10.1161/CIRCULATIONAHA.107.716951 10.1161/CIRCULATIONAHA.107.716951 . DOI: 10.1016/j.jvs.2008.10.042 http://doi.org/10.1016/j.jvs.2008.10.042 http://circ.ahajournals.org/cgi/doi/10.1161/CIRCULATIONAHA.107.716951 http://circ.ahajournals.org/cgi/doi/10.1161/CIRCULATIONAHA.107.716951

Lee T , Derebail VK , Kshirsagar AV , et al . Patients with primary membranous nephropathy are at high risk of cardiovascular events . Kidney Int 2016 ; 89 ( 5 ): 1111 - 8 . doi: 10.1016/j.kint.2015.12.041 10.1016/j.kint.2015.12.041 . DOI: 10.1016/j.kint.2015.12.041 http://doi.org/10.1016/j.kint.2015.12.041 http://linkinghub.elsevier.com/retrieve/pii/S0085253816002751 http://linkinghub.elsevier.com/retrieve/pii/S0085253816002751

Levey AS , Stevens LA , Schmid CH , et al . A new equation to estimate glomerular filtration rate . Ann Intern Med 2009 ; 150 ( 9 ): 604 - 12 . DOI: 10.7326/0003-4819-150-9-200905050-00006 http://doi.org/10.7326/0003-4819-150-9-200905050-00006 http://annals.org/article.aspx?doi=10.7326/0003-4819-150-9-200905050-00006 http://annals.org/article.aspx?doi=10.7326/0003-4819-150-9-200905050-00006

Troyanov S , Wall CA , Scholey J W , et al . Idiopathic membranous nephropathy: definition and relevance of a partial remission . Kidney Int 2004 ; 66 ( 3 ): 1199 - 205 . doi: 10.1111/j.1523-1755.2004.00873.x 10.1111/j.1523-1755.2004.00873.x DOI: 10.1111/j.1523-1755.2004.00873.x http://doi.org/10.1111/j.1523-1755.2004.00873.x http://linkinghub.elsevier.com/retrieve/pii/S0085253815501749 http://linkinghub.elsevier.com/retrieve/pii/S0085253815501749

Radhakrishnan J , Appel AS , Valeri A , et al . The nephrotic syndrome, lipids, and risk factors for cardiovascular disease . Am J Kidney Dis 1993 ; 22 ( 1 ): 135 - 42 . doi: 10.1016/s0272-6386(12)70179-8 10.1016/s0272-6386(12)70179-8 . DOI: 10.1016/S0272-6386(12)70179-8 http://doi.org/10.1016/S0272-6386(12)70179-8 http://linkinghub.elsevier.com/retrieve/pii/S0272638612701798 http://linkinghub.elsevier.com/retrieve/pii/S0272638612701798

Vaziri ND . Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences . Kidney Int 2016 ; 90 ( 1 ): 41 - 52 . doi: 10.1016/j.kint.2016.02.026 10.1016/j.kint.2016.02.026 . DOI: 10.1016/j.kint.2016.02.026 http://doi.org/10.1016/j.kint.2016.02.026 http://linkinghub.elsevier.com/retrieve/pii/S0085253816300047 http://linkinghub.elsevier.com/retrieve/pii/S0085253816300047

Nandwani A , Pathania D , Jha PK , et al . Renal artery thrombosis with renal infarction: a rare cause of acute abdomen . Indian J Nephrol 2017 ; 27 ( 4 ): 313 - 5 . doi: 10.4103/0971-4065.183581 10.4103/0971-4065.183581 . DOI: 10.4103/0971-4065.183581 http://doi.org/10.4103/0971-4065.183581 http://www.indianjnephrol.org/text.asp?2017/27/4/313/183581 http://www.indianjnephrol.org/text.asp?2017/27/4/313/183581

Parag KB , Somers SR , Seedat YK , et al . Arterial thrombosis in nephrotic syndrome . Am J Kidney Dis 1990 ; 15 ( 2 ): 176 - 7 . doi: 10.1016/s0272-6386(12) 80516-6 10.1016/s0272-6386(12) 80516-6 . DOI: 10.1016/S0272-6386(12)80516-6 http://doi.org/10.1016/S0272-6386(12)80516-6 http://linkinghub.elsevier.com/retrieve/pii/S0272638612805166 http://linkinghub.elsevier.com/retrieve/pii/S0272638612805166

Sasaki Y , Raita Y , Uehara G , et al . Carotid thromboembolism associated with nephrotic syndrome treated with dabigatran . Case Rep Nephrol Urol 2014 ; 4 ( 1 ): 42 - 52 . doi: 10.1159/000362162 10.1159/000362162 . DOI: 10.1159/000362162 http://doi.org/10.1159/000362162 https://www.karger.com/Article/FullText/362162 https://www.karger.com/Article/FullText/362162

Singhal R , Brimble KS . Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management . Thromb Res 2006 ; 118 ( 3 ): 397 - 407 . doi: 10.1016/j.thromres.2005.03.030 10.1016/j.thromres.2005.03.030 . DOI: 10.1016/j.thromres.2005.03.030 http://doi.org/10.1016/j.thromres.2005.03.030 http://linkinghub.elsevier.com/retrieve/pii/S0049384805002136 http://linkinghub.elsevier.com/retrieve/pii/S0049384805002136

Li SJ , Guo JZ , Zuo K , et al . Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study . Thromb Res 2012 ; 130 ( 3 ): 501 - 5 . doi: 10.1016/j.thromres.2012.04.015 10.1016/j.thromres.2012.04.015 . DOI: 10.1016/j.thromres.2012.04.015 http://doi.org/10.1016/j.thromres.2012.04.015 http://linkinghub.elsevier.com/retrieve/pii/S0049384812002058 http://linkinghub.elsevier.com/retrieve/pii/S0049384812002058

Lionaki S , Derebail VK , Hogan SL , et al . Venous thromboembolism in patients with membranous nephropathy . Clin J Am Soc Nephrol 2012 ; 7 ( 1 ): 43 - 51 . doi: 10.2215/CJN.04250511 10.2215/CJN.04250511 . DOI: 10.2215/CJN.04250511 http://doi.org/10.2215/CJN.04250511 http://cjasn.asnjournals.org/cgi/doi/10.2215/CJN.04250511 http://cjasn.asnjournals.org/cgi/doi/10.2215/CJN.04250511

Llach F . Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome . Kidney Int 1985 ; 28 ( 3 ): 429 - 39 . doi: 10.1038/ki.1985.149 10.1038/ki.1985.149 . DOI: 10.1038/ki.1985.149 http://doi.org/10.1038/ki.1985.149 http://linkinghub.elsevier.com/retrieve/pii/S0085253815334979 http://linkinghub.elsevier.com/retrieve/pii/S0085253815334979

Bellomo R , Atkins RC . Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron 1993 ; 63 ( 3 ): 249 - 54 . doi: 10.1159/000187205 10.1159/000187205 . DOI: 10.1159/000187205 http://doi.org/10.1159/000187205 https://www.karger.com/Article/FullText/187205 https://www.karger.com/Article/FullText/187205

Ponticelli C , Glassock RJ . Glomerular diseases: membranous nephropathy-a modern view . Clin J Am Soc Nephrol 2014 ; 9 ( 3 ): 609 - 16 . doi: 10.2215/CJN.04160413 10.2215/CJN.04160413 . DOI: 10.2215/CJN.04160413 http://doi.org/10.2215/CJN.04160413 http://cjasn.asnjournals.org/cgi/doi/10.2215/CJN.04160413 http://cjasn.asnjournals.org/cgi/doi/10.2215/CJN.04160413

0

Views

4403

Downloads

2

CSCD

>

Alert me when the article has been cited

Submit

Publicity Resources

Related Articles

No data

Related Author

No data

Related Institution

No data

⁰